Intravenous Infusions Plc (GHSE:IIL)

Intravenous Infusions Statistics

Total Valuation

GHSE:IIL has a market cap or net worth of GHS 13.72 million. The enterprise value is 20.96 million.

Market Cap	13.72M
Enterprise Value	20.96M

Important Dates

The next estimated earnings date is Wednesday, December 10, 2025.

Earnings Date	Dec 10, 2025
Ex-Dividend Date	n/a

Share Statistics

GHSE:IIL has 274.41 million shares outstanding. The number of shares has decreased by -2.87% in one year.

Current Share Class	274.41M
Shares Outstanding	274.41M
Shares Change (YoY)	-2.87%
Shares Change (QoQ)	-0.70%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.71
PB Ratio	0.86
P/TBV Ratio	0.86
P/FCF Ratio	3.08
P/OCF Ratio	2.16
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-17.87
EV / Sales	1.08
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	4.70

Financial Position

The company has a current ratio of 0.84, with a Debt / Equity ratio of 0.52.

Current Ratio	0.84
Quick Ratio	0.60
Debt / Equity	0.52
Debt / EBITDA	n/a
Debt / FCF	1.86
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -6.96% and return on invested capital (ROIC) is -5.37%.

Return on Equity (ROE)	-6.96%
Return on Assets (ROA)	-3.18%
Return on Invested Capital (ROIC)	-5.37%
Return on Capital Employed (ROCE)	-10.97%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.43
Inventory Turnover	2.10

Taxes

In the past 12 months, GHSE:IIL has paid 41,464 in taxes.

Income Tax	41,464
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	0.16
52-Week Price Change	n/a
50-Day Moving Average	0.05
200-Day Moving Average	0.06
Relative Strength Index (RSI)	54.61
Average Volume (20 Days)	25,352

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, GHSE:IIL had revenue of GHS 19.40 million and -1.17 million in losses. Loss per share was -0.00.

Revenue	19.40M
Gross Profit	6.80M
Operating Income	-2.28M
Pretax Income	-1.13M
Net Income	-1.17M
EBITDA	-1.72M
EBIT	-2.28M
Loss Per Share	-0.00

Balance Sheet

The company has 1.06 million in cash and 8.30 million in debt, giving a net cash position of -7.24 million or -0.03 per share.

Cash & Cash Equivalents	1.06M
Total Debt	8.30M
Net Cash	-7.24M
Net Cash Per Share	-0.03
Equity (Book Value)	15.88M
Book Value Per Share	0.06
Working Capital	-3.48M

Cash Flow

In the last 12 months, operating cash flow was 6.36 million and capital expenditures -1.90 million, giving a free cash flow of 4.46 million.

Operating Cash Flow	6.36M
Capital Expenditures	-1.90M
Free Cash Flow	4.46M
FCF Per Share	0.02

Margins

Gross margin is 35.04%, with operating and profit margins of -11.76% and -6.05%.

Gross Margin	35.04%
Operating Margin	-11.76%
Pretax Margin	-5.83%
Profit Margin	-6.05%
EBITDA Margin	-8.86%
EBIT Margin	-11.76%
FCF Margin	22.98%

Dividends & Yields

This stock pays an annual dividend of 0.00, which amounts to a dividend yield of 5.60%.

Dividend Per Share	0.00
Dividend Yield	5.60%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	2.87%
Shareholder Yield	8.47%
Earnings Yield	-8.55%
FCF Yield	32.48%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

GHSE:IIL has an Altman Z-Score of 0.57 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.57
Piotroski F-Score	3